Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/17/2017 02/21/2017 02/22/2017 02/23/2017 02/24/2017 Date
6.02(c) 5.87(c) 5.47(c) 5.63(c) 5.66(c) Last
88 401 88 403 108 783 88 622 45 640 Volume
+3.79% -2.49% -6.81% +2.93% +0.53% Change
More quotes
Financials ($)
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
02/12 OSIRIS THERAPEUTICS,INC. (NASDAQ : OSIR) Files An 8-K Departure of Directors or ..
02/10 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
02/10 Osiris Appoints Uwe Sommer and Thomas Knapp to its Board of Directors
01/31 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
01/20 OSIRIS THERAPEUTICS : announced a Comparative Effectiveness Study on the Use of ..
01/19 Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of..
01/14 OSIRIS THERAPEUTICS : Announces Scientific Manuscript Reporting Antimicrobial Pr..
01/13 Osiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial P..
01/12 OSIRIS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
2016 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
More news
Sector news : Bio Therapeutic Drugs
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/30Want the latest upgrades & downgrades for $OSIR $UNM $EMCI $CPXGF $ZAVVV?.. 
01/25Healthcare - Top 5 Gainers / Losers as of 11:30 am  
01/06Want the latest upgrades & downgrades for $CPXGF $OSIR $UNM $EMCI $ZAVVV?.. 
2016$OSIR Osiris Therapeutics Grafix wound treatment product is now covered by Ae..
5
More tweets
Qtime:11
News from SeekingAlpha
01/25 HEALTHCARE - TOP 5 GAINERS / LOSERS : 30 am
2016 Orthofix Poised To Plunge 50% On Undisclosed FDA Issue And Accounting Manipul..
2016 Adds and drops from the Nasdaq Biotech Index
2016 OSIRIS THERAPEUTICS : Regenerative Technologies And Restated Financials
2016 Midday Gainers / Losers
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David A. Dresner President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Gregory I. Law Chief Financial Officer, Secretary & Treasurer
Alla Danilkovitch Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, I..14.66%195
AMGEN, INC.19.01%128 555
GILEAD SCIENCES, INC.-3.13%92 143
CELGENE CORPORATION3.21%91 979
REGENERON PHARMACEUTIC..-1.67%38 296
ACTELION LTD22.45%28 792
More Results